Human CAR-T Cell Glioblastoma Trial Generates Clues for Improving Treatment – Genetic Engineering & Biotechnology News
Medical Xpress |
Human CAR–T Cell Glioblastoma Trial Generates Clues for Improving Treatment
Genetic Engineering & Biotechnology News A chimeric antigen receptor T–cell (CAR-T) therapy for glioblastoma (GBM) successfully crossed the blood–brain barrier to reach tumors in the brain, appeared safe, and reduced levels of its epidermal growth factor variant III (EGFRvIII) tumor target in … Combining CAR T cells with existing immunotherapies may overcome resistance in glioblastomas |
